Marinomed Biotech AG
MARI.VI · VIE
6/30/2025 | 3/31/2025 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €1,487 | – | €912 | €1,856 |
| Short-Term Investments | €0 | – | €0 | €0 |
| Receivables | €1,251 | – | €2,452 | €1,923 |
| Inventory | €0 | – | €813 | €1,057 |
| Other Curr. Assets | €121 | – | -€0 | €2 |
| Total Curr. Assets | €2,983 | – | €4,176 | €4,838 |
| Property Plant & Equip (Net) | €4,642 | – | €5,753 | €5,848 |
| Goodwill | €0 | – | €0 | €0 |
| Intangibles | €17 | – | €1,389 | €1,456 |
| Long-Term Investments | €0 | – | €0 | €0 |
| Tax Assets | €0 | – | €0 | €0 |
| Other NC Assets | €0 | – | €4 | €6 |
| Total NC Assets | €4,659 | – | €7,147 | €7,310 |
| Other Assets | €0 | – | €0 | €0 |
| Total Assets | €7,642 | – | €11,323 | €12,148 |
| Liabilities | – | – | – | – |
| Payables | €284 | – | €579 | €580 |
| Short-Term Debt | €3,296 | – | €24,231 | €596 |
| Tax Payable | €0 | – | €0 | €0 |
| Deferred Revenue | €0 | – | €0 | €0 |
| Other Curr. Liab. | €1,523 | – | €1,951 | €1,406 |
| Total Curr. Liab. | €5,103 | – | €26,761 | €2,581 |
| LT Debt | €7,417 | – | €4,861 | €21,150 |
| Deferred Rev, NC | €0 | – | €0 | €0 |
| Deferred Tax Liab, NC | €0 | – | €0 | €0 |
| Other NC Liab. | €561 | – | €247 | €258 |
| Total NC Liab. | €7,978 | – | €5,108 | €21,408 |
| Other Liabilities | €0 | – | €0 | €0 |
| Cap. Leases | €0 | – | €0 | €0 |
| Total Liabilities | €13,080 | – | €31,868 | €23,989 |
| Equity | – | – | – | – |
| Pref Stock | €0 | – | €0 | €0 |
| Common Stock | €1,778 | – | €1,541 | €1,541 |
| Retained Earnings | -€50,214 | – | -€67,384 | -€58,680 |
| AOCI | €0 | – | €45,299 | €0 |
| Other Equity | €42,997 | – | €0 | €45,299 |
| Total Equity | -€5,438 | – | -€20,545 | -€11,841 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | – | €0 | €0 |
| Total Liab. & Tot. Equity | €7,642 | – | €11,323 | €12,148 |
| Net Debt | €9,226 | €0 | €28,180 | €19,890 |